US FDA Approves First Drug To Cut Death Risk By 55% In Niemann-Pick Patients: What Is The Rare Disease?

US FDA Approves First Drug To Cut Death Risk By 55% In Niemann-Pick Patients: What Is The Rare Disease?

Credit: AI image

Text

Updated Nov 18, 2026 | 07:02 AM IST

SummaryNiemann-Pick disease type C (NPC) is a rare inherited disorder that affects the body's ability to process cholesterol. Lembaz addresses this underlying cause, extending life expectancy.

End of Article